Cargando…
ATAD2 is a driver and a therapeutic target in ovarian cancer that functions by upregulating CENPE
Ovarian cancer is a complex disease associated with multiple genetic and epigenetic alterations. The emergence of treatment resistance in most patients causes ovarian cancer to become incurable, and novel therapies remain necessary. We identified epigenetic regulator ATPase family AAA domain-contain...
Autores principales: | Guruvaiah, Praveen, Chava, Suresh, Sun, Chiao-Wang, Singh, Nirupama, Penn, Courtney A., Gupta, Romi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362061/ https://www.ncbi.nlm.nih.gov/pubmed/37479754 http://dx.doi.org/10.1038/s41419-023-05993-9 |
Ejemplares similares
-
Changes in the Transcriptome and Chromatin Landscape in BRAFi-Resistant Melanoma Cells
por: Reddi, Kiran Kumar, et al.
Publicado: (2022) -
Disruptor of telomeric silencing 1-like promotes ovarian cancer tumor growth by stimulating pro-tumorigenic metabolic pathways and blocking apoptosis
por: Chava, Suresh, et al.
Publicado: (2021) -
Co-targeting of specific epigenetic regulators in combination with CDC7 potently inhibit melanoma growth
por: Chava, Suresh, et al.
Publicado: (2022) -
Identification of the Mutational Landscape of Gynecological Malignancies
por: Chava, Suresh, et al.
Publicado: (2020) -
UBE2T promotes breast cancer tumor growth by suppressing DNA replication stress
por: Dutta, Roshan, et al.
Publicado: (2022)